Poietis develops and produces human, customized tissues using 4D bioprinting for pharmaceutical and cosmetic applications as well as regenerative medicine. Complex 3D tissues are obtained by high resolution Laser-Assisted Bioprinting. Poietis is the result of over 10 years of research conducted at INSERM (France’s National Institute for Health and Medical Research) and the University of Bordeaux. The company was founded in 2014 and headquartered in Pessac, France. It has raised $9M in series a funding, with backing from Europa, Aquiti Gestion. The company operates in the Life Sciences - Life Sciences Platforms and Tools, High Tech - 3D Printing space. Laser-assisted 3D bioprinting technology.
← All startups
Poietis
Series APoietis develops and produces human, customized tissues using 4D bioprinting for pharmaceutical and cosmetic applications as well as regenerative medicine. Complex 3D tissues are obtained by high resolution Laser-Assisted Bioprinting. Poietis is the result of over 10 years of research conducted at INSERM (France’s National Institute for Health and Medical Research) and the University of Bordeaux. The company was…
About
Business model
3D Printing > Hardware > 3D Printers > Industrial Grade > Industry Based > 3D Bio Printers,
Life Sciences Platforms and Tools > Research Services > Diversified
Institutional investors
EuropaAquiti Gestion
Latest coverage
📰 See all funding news — keep up with the raises that set comps.
Investor directory
🗂️ Browse all funds in our directory — active VCs and growth investors by stage and sector.